Clinical Trials Directory

Trials / Completed

CompletedNCT00204425

Effect of Exercise Training and Soy-based Nutritional Supplementation on Prevention of Osteoporosis

Effect of Combined Exercise Therapy and Isoflavone Supplementation on Prevention of Osteoporosis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
351 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine the effectiveness of combining exercise training (i.e. weight lifting and walking) and dietary supplementation with a soy-based nutritional supplement for increasing bone mineral density. We hypothesize that the exercise training and soy-based supplement will be additive for increasing bone mineral density.

Detailed description

Exercise training is effective for increasing bone mineral density and preventing osteoporosis, but the effects are small. When estrogen replacement is given to post-menopausal women the effectiveness of exercise training for improving bone mineral density is increased. Currently many women are concerned about the risks of taking hormone-replacement therapy and are seeking alternative therapies. The purpose of our study therefore is to use an estrogen-like dietary supplement derived from soy called a phytoestrogen (soy isoflavone) combined with exercise training for improving bone mineral density. Comparisons: Four groups are being compared: 1) Exercise training (i.e. weight lifting 2 times per week and walking 4 times per week) plus soy isoflavone (90 mg aglycone equivalents per day); 2) Exercise training plus placebo; 3) Exercise placebo (flexibility exercises four times per week) plus soy isoflavone; 4) Exercise placebo plus placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTexercise/soy isoflavoneExercise 6 days per week, 90 mg/day aglycone isoflavone Exercise placebo (stretching), isoflavone placebo

Timeline

Start date
2004-12-01
Primary completion
2007-12-01
Completion
2010-04-01
First posted
2005-09-20
Last updated
2011-09-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00204425. Inclusion in this directory is not an endorsement.